Foundation News

There is hope (and need) for male contraception

Vasalgel and other new male contraceptives were highlighted in an article in The Telegraph. Written by Aaron Hamlin, the executive director of the Male Contraception Initiative, the piece offers hope that men and their partners will have more and better options for reproductive control in just a few years. The article points out that Vasalgel is poised to be the first approved male contraceptive since the condom. To stay up to date on Vasalgel’s development, sign up for our newsletters. Or consider a donation to Parsemus Foundation in support of Vasalgel.